We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.75 | 2.75% | 28.00 | 27.60 | 28.00 | 27.80 | 27.25 | 27.25 | 2,193,935 | 16:35:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 56.04M | 16.12M | 0.0237 | 11.73 | 185.4M |
TIDMVENN
Venn Life Sciences Holdings PLC
02 April 2015
Venn Life Sciences Holdings Plc
("Venn" or the "Company" or the "Group")
Investor teach-in
Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, will be hosting a teach-in where Tony Richardson, CEO will provide an overview and strategy of the Company on Tuesday 21 April 2015. No new material trading or financial information will be disclosed.
The event is open to all investors and analysts and will be held from 16:30 until 19:30 in the Black Bar at Rocket Bar, 6 Adams Court, Old Broad Street, London, EC2N 1DX and will be followed by drinks and canapés.
To register for the event, please email venn@walbrookpr.com or call the Walbrook PR team below.
Enquiries:
Venn Life Sciences Holdings Plc www.vennlifesciences.com Tony Richardson, Chief Executive Officer Tel: +353 154 99 341 Orla Mc Guinness, Marketing Manager Tel: +33 676 93 11 78 Zeus Capital (Nominated Adviser and Broker) Ross Andrews/Andrew Jones Tel: 0161 831 1512 Alex Davies Tel: 020 7533 7727 Walbrook PR Ltd Tel: +44 (0)20 7933 8780 or venn@walbrookpr.com Paul McManus Mob: +44 (0)7980 541 893 Lianne Cawthorne Mob: +44 (0)7584 391 303
About Venn Life Sciences Limited:
Venn Life Sciences is a Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAFLLFBEZFEBBX
1 Year Hvivo Chart |
1 Month Hvivo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
